Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes retail...

    NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-05-04T12:31:24+05:30  |  Updated On 17 Aug 2021 11:58 AM IST

    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 20 drug formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).


    Many medicines whose price have been fixed by NPPA include fixed-dose combination and other medicines to control Blood Pressure, dual antiplatelet therapy, cold medication, epilepsy, IBD medications, antibiotics and more

    The drug formulations whose price has been fixed include combinations of Teneligliptin + Metformin Tablet; Paracetamol + Phenylephrine + Caffeine (Anhydrous) + Diphenhydramine Tablet; Clopidogrel + Aspirin tablet and others.


    Notable drug makers inclusive of Sun Pharma, Emcure Pharma, Dr Reddy's Lab, Cipla, Akums Drugs, Torrent Pharma, Zydus Healthcare, Hetero Labs, Intas Pharma and others are responsible for the manufacture of these formulations.


    Many FDC whose price have been fixed are commonly used. For instance, Clopidogrel in combination with Aspirin tablet is used to treat worsening chest pain (new heart attack, unstable angina) and to keep blood vessels open and prevent blood clots after certain procedures (such as a cardiac stent).


    While another combination of Medoxomil + Amlodipine + Hydrochlorothiazide Tablet manufactured by Hyderabad based Dr Reddy's under the trademark Trisertain is indicated for treating is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems.


    The detail of the medicines issued by NPPA reads;






















































































































































































    Sl.

    No.
    Name of the Formulation /

    Brand Name
    StrengthUnitManufacturer & Marketing CompanyRetail Price

    (Rs.)
    (1)(2)(3)(4)(5)(6)
    1.Mesalazine SachetEach sachet contains: Mesalazine IP 2gm (As Coated

    Granules)
    2gm SachetM/s Sun Pharma Laboratories Limited86.78
    2.Mesalazine SachetEach sachet contains:

    Mesalazine IP 1gm (As Coated Granules)
    1gm SachetM/s Sun Pharma Laboratories Limited43.28
    3.Clotrimazole + Beclomethasone + Neomycin CreamCream contains: Clotrimazole 1.0% w/w

    Beclomethasone Dipropionate 0.025% w/w Neomycin Sulphate eq.

    to Neomycin 0.5%w/w Cream


    1 gm
    M/s Helios Pharmaceuticals / M/s Emcure Pharmaceuticals

    Limited
    5.34
    4.Telmisartan + Cilnidipine + Chlorthalidone TabletEach film coated bilayered tablet contains:

    Telmisartan IP 40mg,

    Cilnidipine 10mg, Chlorthalidone IP 6.25mg


    1 Tablet


    M/s Swiss Garnier Genexiaa Sciences / M/s Cipla Limited
    10.72
    5.Telmisartan + Cilnidipine TabletEach film coated tablet contains:

    Telmisartan IP 40mg, Cilnidipine 10mg


    1 Tablet
    M/s Swiss Garnier

    Genexiaa Sciences / M/s Cipla Limited
    7.66
    6.Paracetamol + Phenylephrine + Caffeine (Anhydrous) + Diphenhydramine

    Tablet
    Each uncoated tablets contains: Paracetamol IP 500mg, Phenylephrine HCL IP 5mg, Caffeine (Anhydrous) IP 30mg, Diphenhydramine HCL IP 25mg,



    1 Tablet
    M/s Samson Laboratories Pvt. Ltd. / M/s Intas Pharmaceuticals Limited2.80
    7.Methylcobalamin + Pyridoxine +

    Folic Acid Tablet
    Each film coated tablet contains: Methylcobalamin (Extended Release) IP 1500mcg,

    Pyridoxine Hydrochloride IP 20mg, Folic Acid IP 5mg


    1 Tablet


    M/s Tirupati Medicare Ltd. / M/s Cipla Limited
    15.00
    8.OlmesartanEach film coated tablet contains:1 TabletM/s Akums Drugs and10.54
    9.Olmesartan Medoxomil + Amlodipine + Hydrochlorothiazide Tablet (Trisertain

    40)
    Each film coated tablet contains: Olmesartan Medoxomil IP 40mg, Amlodipine Besilate IP eq. to Amlodipine 5mg, Hydrochlorothiazide IP 12.5mg



    1 Tablet


    M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Dr. Reddy's Laboratories Limited
    14.56
    10.Olmesartan Medoxomil + Amlodipine Tablet

    (Olsertain AM 40)
    Each film coated tablet contains: Olmesartan Medoxomil IP 40mg, Amlodipine Besilate IP eq. to

    Amlodipine 5mg,


    1 Tablet
    M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Dr. Reddy's

    Laboratories Limited
    14.45
    11.Levetiracetam Tablet (Epictal)Each film coated tablet contains: Levetiracetam IP 1000mg

    1 Tablet
    M/s Akums Drugs and Pharmaceuticals Ltd. / M/s IPCA Laboratories

    Limited
    24.56
    12.Linezolid + Dextrose Injection (ZIFI TURBO 600)Each 100ml injection contains: Linezolid IP 200mg

    Dextrose Anhydrous IP 5mg water for Injection q.s.


    Per Pack
    M/s Aishwarya Lifesciences / M/s FDC Limited330.79
    13.Telmisartan + Amlodipine + Chlorthalidone TabletEach film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg,

    Chlorthalidone 6.25mg Tablets


    1 Tablet
    M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited9.30
    14.Telmisartan + Amlodipine + Chlorthalidone TabletEach film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besylate IP eq. to

    Amlodipine 5mg, Chlorthalidone 12.5mg Tablets


    1 Tablet
    M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited9.81
    15.Clopidogrel + Aspirin tabletEach film coated tablet contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg,

    Aspirin 75mg


    1 Tablet
    M/s Rivpra Formulation Pvt. Ltd. / M/s Cadila Pharmaceuticals

    Limited
    3.31
    16.Teneligliptin + Metformin Tablet (TENELICAS M)Each uncoated bilayered tablet contains:

    Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg

    Metformin HCl 500mg (ER)


    1 Tablet
    M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Anthus

    Pharmaceuticals Pvt. Ltd.
    9.81
    17.Tenofovir Alafenamide Tablet (Tenocruz – AF)Each film coated tablet contains: Tenofovir Alafenamide Hemifumarate eq. to Tenofovir Alafenamide 25mg

    1 Tablet
    M/s Hetero Labs Ltd./ M/s Torrent Pharmaceuticals

    Limited
    44.29
    18.Clarithromycin tablet, Esomeprazole Tablet, Amoxycillin TabletEach Strip contains:

    a. Clarithromycin tablets IP 2 tablets: Each enteric coated tablet contains:

    Clarithromycin IP 500mg

    b. Esomeprazole Tablets IP 2 Tablets, Each film coated tablet contains: Esomeprazole Magnesium IP eq. to

    Esomeprazole 40mg,

    c. Amoxycillin Tablets USP 2 tablets, Each film coated tablet contains: Amoxycillin Trihydrate IP eq. to

    Amoxycillin 750mg




    Per Strip




    M/s Malik Lifesciences Pvt. Ltd. / M/s Cipla Limited
    136.80
    19.Heavy Magnesium Oxide+ Vitamin C + Niacinamide + Zinc Oxide + Vitamin E + Calcium Pantothenate

    +Vitamin A + Cupric Oxide + Manganese Sulfate + Thiamine Mononitrate + Riboflavin + Pyridoxine Hydrochloride + Folic Acid + Chromium Picolinate + Biotin + Selenious Acid + Vitamin D3 + Methylcobalamin + L-Glutamic Acid + Dl-Methionime Tablet (One up Gold D)
    Each film coated tablet contains: Heavy Magnesium Oxide IP 30mg, Vitamin C IP 100mg, Niacinamide IP 50mg,

    Zinc Oxide IP Eq. to Elemental Zinc 22.5mg,

    Vitamin E Acetate IP 25IU, Calcium Pantothenate IP 12.5mg,

    Vitamin A Concentrate Powder IP 5000IU,

    Cupric Oxide eq. to Elemental Copper 2.5mg,

    Manganese Sulfate Usp eq. to Elemental Manganese 2.5mg, Thiamine Mononitrate IP 10mg, Riboflavin IP 10mg,

    Pyridoxine Hydrochloride IP 3mg, Folic Acid IP 1500mcg,

    Chromium Picolinate USP eq. to Elemental Chromium 100mcg, Biotin USP 60mcg,

    Selenious Acid USP eq. to Elemental Selenium 60mcg,

    Vitamin D3 IP400IU, Methylcobalamin IP 500mcg,

    L-Glutamic Acid USP 100mg, Dl-Methionime BP 25mg






















    1 Tablet


















    M/s Akums Drugs and Pharmaceuticals Limited / M/s Torrent Pharmaceuticals Limited
    5.08
    20.Darunavir + Ritonavir Tablet (Danavir 600 R)Each film coated tablet contains: Darunavir Ethanolate eq. to Darunavir 600mg,

    Ritonavir 100mg


    1 Tablet
    M/s Hetero Labs Limited / M/s Hetero Healthcare Limited160.71

    The NPPA notice further reads;




    • The manufacturer of above mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table

    • The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said

    • The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and

    • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the

    • The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

    • In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act,

    • Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)


    Also Read: Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

    Akums DrugsAmlodipineAspirinCiplaclopidogrelDr Reddys LabEmcure PharmaEpictalHetero LabsHydrochlorothiazide tabletsIntas PharmaMedoxomilMetforminNational Pharmaceutical Pricing AuthorityNPPAOlsertainParacetamolSun PharmaTenofovir Alafenamide TabletTorrent PharmaTrisertainZydus Healthcare

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok